In conclusion, this study highlights Humanin as a key regulator of endothelial function and a potential biomarker for predicting cardiovascular outcomes and mortality in RA patients, contributing to a deeper understanding of the molecular mechanisms linking RA, endothelial dysfunction, and cardiovascular risk in this vulnerable patient population. This evidence concerns the gene MT-RNR2 and endothelial dysfunction.